AmerisourceBergen Corporation – Consensus Indicates Potential 20.1% Upside
AmerisourceBergen Corporation found using ticker (ABC) have now 12 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 187 and 150 with a mean TP of 170.67. Now with the previous closing price of 142.14 this is indicating there is a potential upside of 20.1%. The day 50 moving average is 146.35 and the 200 day MA is 139.47. The market capitalisation for the company is $29,849m. You can visit the company''s website by visiting: https:||www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets="ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $35,840m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
AmerisourceBergen Corporation – Consensus Indicates Potential 20.1% Upside
AmerisourceBergen Corporation found using ticker (ABC) have now 12 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 187 and 150 with a mean TP of 170.67. Now with the previous closing price of 142.14 this is indicating there is a potential upside of 20.1%. The day 50 moving average is 146.35 and the 200 day MA is 139.47. The market capitalisation for the company is $29,849m. You can visit the company''s website by visiting: https:||www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets="ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $35,840m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.